OVERVIEW

Amid the global esoteric testing market size is expected to hit USD 41.3 billion by 2026, growing over the forecast period at a CAGR of 10.03%. Increasing demand for early and reliable diagnosis of disease, growing infectious disease prevalence, increasing public-private investment as well as research funding & grants to improve advanced laboratory testing methods, and developments in medical diagnostic techniques are key drivers of market growth. The report will also account for COVID-19 as a key market contributor.

TABLE OF CONTENT

1 Global Esoteric Testing Market

• 1.1 Study Objectives
• 1.2 Market Definition
• 1.3 Study Scope
  • 1.3.1 Markets Covered
  • 1.3.2 Geographic Scope

• 2 RESEARCH METHODOLOGY
  • 2.1 Research Data
    • 2.1.1 Secondary Data
      • 2.1.1.1 Key Data From Secondary Sources
    • 2.1.2 Primary Data
      • 2.1.2.1 Key Data From Primary Sources
      • 2.1.2.2 Key Industry Insights
      • 2.1.2.3 Breakdown of Primaries
  • 2.2 Market Size Estimation
    • 2.2.1 Bottom-Up Approach
    • 2.2.2 Top-Down Approach
  • 2.3 Market Breakdown and Data Triangulation
  • 2.4 Research Assumptions

• 3 Global Esoteric Testing Market – Executive Summary
  • 3.1 Market Revenue, Market Size and Key Trends by Company
  • 3.2 Key Trends by type of Application
  • 3.3 Key Trends segmented by Geography

• 4 Global Esoteric Testing Market – Comparative Analysis
  • 4.1 Product Benchmarking - Top 10 companies
  • 4.2 Top 5 Financials Analysis
  • 4.3 Market Value split by Top 10 companies
  • 4.4 Patent Analysis - Top 10 companies
  • 4.5 Pricing Analysis

• 5 Global Esoteric Testing Market – Industry Market Entry Scenario
  • 5.1 Regulatory Framework Overview
  • 5.2 New Business and Ease of Doing business index
  • 5.3 Case studies of successful ventures
  • 5.4 Customer Analysis – Top 10 companies

• 6 Global Esoteric Testing Market - Market Forces
  • 6.1 Introduction
  • 6.2 Market Dynamics
    • 6.2.1 Drivers
    • 6.2.2 Opportunities
    • 6.2.3 Challenges
  • 6.3 Porters Analysis of Market
    • 6.3.1 Bargaining power of suppliers
    • 6.3.2 Bargaining powers of customers
    • 6.3.3 Threat of new entrants
    • 6.3.4 Rivalry among existing players
    • 6.3.5 Threat of substitutes

• 7 Global Esoteric Testing Market - Strategic Analysis
  • 7.1 Value Chain analysis
  • 7.2 Product Life Cycle
  • 7.3 Supplier and distributor analysis (Market share and product dealing strategies)

• 8 Global Esoteric Testing Market – By Type (Market Size – & million/billion)
  • 8.1 Infectious Diseases Testing
  • 8.2 Neurology Testing
  • 8.3 Endocrinology Testing
  • 8.4 Oncology testing
  • 8.5 Immunology Testing
  • 8.6 Genetic Testing
  • 8.7 Others

• 9 Global Esoteric Testing Market - By Technology
  • 9.1 Chemiluminescence Immunoassay (CLIA)
  • 9.2 Enzyme-linked Immunosorbent Assay (ELISA)
  • 9.3 Mass Spectrometry
  • 9.4 Real Time - PCR
  • 9.5 Flow Cytometry
  • 9.6 Radioimmunoassay
  • 9.7 Others

• 10 Global Esoteric Testing Market - By Laboratory Type
  • 10.1 Independent & Reference Laboratories
  • 10.2 Hospital Laboratories

• 11 Global Esoteric Testing Market – By Geography (Market Size – & million/billion)
  • 11.1 Introduction
  • 11.2 North America
    • 11.2.1 US
    • 11.2.2 Canada
    • 11.2.3 Mexico
  • 11.3 Europe
    • 11.3.1 U.K
    • 11.3.2 Germany
    • 11.3.3 Italy
    • 11.3.4 France
    • 11.3.5 Spain
    • 11.3.6 Rest of Europe
  • 11.4 Asia-Pacific
    • 11.4.1 China
    • 11.4.2 Japan
    • 11.4.3 India
    • 11.4.4 South Korea
    • 11.4.5 Rest of APAC
  • 11.5 Rest of the World
    • 11.5.1 South America
    • 11.5.2 Middle East
    • 11.5.3 Africa

• 12 Global Esoteric Testing Market – Entropy
  • 12.1 New product launches
  • 12.2 M&A's, collaborations, JVs and partnerships

• 13 Global Esoteric Testing Market Company Profile (Key Players)
  • 13.1 Market Share, Company Revenue, Products, M&A, Developments
  • 13.2 Labcorp
  • 13.3 Quest Diagnostics
  • 13.4 Sonic Healthcare
  • 13.5 Opko Health
  • 13.6 Miraca Holdings
  • 13.7 Foundation Medicine
  • 13.8 ACM Global Laboratories
  • 13.9 Myriad Genetics
  • 13.10 Primary Health Care
  • 13.11 Healthscope
  • 13.12 Company 11 & more

• 14 Global Esoteric Testing Market - Appendix
  • 14.1 Sources
  • 14.2 Abbreviations